Kenneth A. Buckfire
Founder at Miller Buckfire & Co. LLC
Kenneth A. Buckfire active positions
Companies | Position | Start | End |
---|---|---|---|
Miller Buckfire & Co. LLC
Miller Buckfire & Co. LLC Investment ManagersFinance Miller Buckfire & Co. LLC operates as an investment bank, which provides corporate finance and strategic advisory services. It focuses on addressing transformational issues of clients such as recapitalizations, acquisitions, sales and divestitures, and debt and equity financing transactions. The company was founded by Kenneth A. Buckfire and Henry S. Miller in 2002 and is headquartered in New York, NY. | Founder | 2001-12-31 | - |
President | 2001-12-31 | - | |
New York Philharmonic
New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Director/Board Member | 2010-11-23 | - |
Weill Cornell Medical College | Corporate Officer/Principal | - | - |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | Director/Board Member | - | - |
Career history of Kenneth A. Buckfire
Former positions of Kenneth A. Buckfire
Companies | Position | Start | End |
---|---|---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Corporate Officer/Principal | - | - |
Orpheus Chamber Orchestra, Inc.
Orpheus Chamber Orchestra, Inc. Movies/EntertainmentConsumer Services Orpheus Chamber Orchestra, Inc. engages in the provision of musical experiences. It offers orchestra shows in New York City and around the world. The company was founded in 1972 and is headquartered in New York, NY. | Director/Board Member | - | - |
Dresdner Kleinwort Wasserstein
Dresdner Kleinwort Wasserstein Investment Banks/BrokersFinance Dresdner Kleinwort Wasserstein provides investment banking services. It offers general financial advice together with execution capability for a range of corporate finance related transactions on a global basis. The primary focus is on mergers and acquisitions, disposals, equity issues and initial public offerings. The company is headquartered in Frankfurt am Main, Germany. | Chief Executive Officer | - | - |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Director/Board Member | 2013-05-05 | - |
Training of Kenneth A. Buckfire
The Trustees of Columbia University in The City of New York | Masters Business Admin |
University of Michigan | Undergraduate Degree |
Statistics
International
United States | 9 |
Germany | 2 |
Belgium | 2 |
Operational
Director/Board Member | 4 |
Corporate Officer/Principal | 2 |
Founder | 1 |
Sectoral
Consumer Services | 6 |
Finance | 4 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 7 |
---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Miller Buckfire & Co. LLC
Miller Buckfire & Co. LLC Investment ManagersFinance Miller Buckfire & Co. LLC operates as an investment bank, which provides corporate finance and strategic advisory services. It focuses on addressing transformational issues of clients such as recapitalizations, acquisitions, sales and divestitures, and debt and equity financing transactions. The company was founded by Kenneth A. Buckfire and Henry S. Miller in 2002 and is headquartered in New York, NY. | Finance |
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
Dresdner Kleinwort Wasserstein
Dresdner Kleinwort Wasserstein Investment Banks/BrokersFinance Dresdner Kleinwort Wasserstein provides investment banking services. It offers general financial advice together with execution capability for a range of corporate finance related transactions on a global basis. The primary focus is on mergers and acquisitions, disposals, equity issues and initial public offerings. The company is headquartered in Frankfurt am Main, Germany. | Finance |
New York Philharmonic
New York Philharmonic Movies/EntertainmentConsumer Services New York Philharmonic provides live theatrical presentations. The company was founded in 1842 and is headquartered in New York, NY. | Consumer Services |
Orpheus Chamber Orchestra, Inc.
Orpheus Chamber Orchestra, Inc. Movies/EntertainmentConsumer Services Orpheus Chamber Orchestra, Inc. engages in the provision of musical experiences. It offers orchestra shows in New York City and around the world. The company was founded in 1972 and is headquartered in New York, NY. | Consumer Services |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Amyl Therapeutics SRL is a Belgian biotech company that uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-? (A?), tau, and ?-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases. Amyl Therapeutics is based in Liege, BE and was founded in November 2020 by Drs. The company's therapies based on the clarity technology platform are designed to prevent the further accumulation of aggregates and clear existing aggregates from the peripheral organs and the brain, while also blocking further cell-to-cell spread of misfolded proteins. Florent Gros and Pierre Vandepapelière. Pierre Vandepapelière has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Kenneth A. Buckfire
- Experience